www.fdanews.com/articles/72863-mochida-to-become-sole-distributor-of-ortho-oral-contraceptive
Mochida to Become Sole Distributor of Ortho Oral Contraceptive
June 1, 2005
Mochida Pharmaceutical announced that it will become a sole distributor of Ortho 777-21 and OrthoM-21, low-dose oral contraceptives (triphasic and monophasic, respectively) currently co-marketed with Jannssen Pharmaceutical, as of June 1. Manufactured by U.S. Ortho-McNeil Pharmaceutical, the Ortho contraceptives has been marketed in Japan since 1999. The decision will allow Mochida to strengthen its presence in the obstetric and gynecologic field.
()a href="http://www.japancorp.net/Article.Asp?Art_ID=10183" target="_blank">Japan Corporate News Network